Seminars in Hematology
Volume 42, Issue 1 , Pages 49-55 , January 2005

von Willebrand factor and factor VIII as risk factors for arterial and venous thrombosis

  • Ida Martinelli

      Affiliations

    • Angelo Bianchi Bonomi Hemophilia and Thrombosis Center, Department of Internal Medicine and Dermatology, IRCCS Ospedale Maggiore Policlinico, University of Milan, Milan, Italy
    • Corresponding Author InformationAddress correspondence to Ida Martinelli, MD, PhD, Hemophilia and Thrombosis Center, IRCCS Maggiore Hospital Policlinico, University of Milano, Via Pace, 9, 20122 Milano, Italy

References 

  1. Weiss HJ , Sussman II , Hoyer LW . Stabilization of factor VIII in plasma by the von Willebrand factor . J Clin Invest . 1977;60:390–404
  2. Bloom AL , Giddings JC , Wilks CJ . Factor VIII on the vascular intima (Possible importance in haemostasis and thrombosis) . Nat New Biol . 1973;241:217–219
  3. Hoyer L , de los Santos R , Hoyer J . Antihemophilic factor antigen. Localization in endothelial cells by immunofluorescent microscopy . J Clin Invest . 1973;52:2737–2744
  4. Jaffe E , Hoyer LW , Nachman RL . Synthesis of antihemophilic factor antigen by cultured human endothelial cells . J Clin Invest . 1973;52:2757–2764
  5. Sakariassen KS , Bolhuis PA , Sixma JJ . Human blood platelet adhesion to artery subendothelium is mediated by factor VIII-von Willebrand factor bound to the subendothelium . Nature . 1979;279:636–638
  6. Sporn LA , Marder VJ , Wagner DD . Inducible secretion of large, biologically potent von Willebrand factor multimers . Cell . 1986;46:185–190
  7. Wise RJ , Dorner AJ , Krane M , Pittman DD , Kaufman RJ . The role of von Willebrand factor multimerization and propeptide cleavage in the binding and stabilization of factor VIII . J Biol Chem . 1991;266:21948–21955
  8. Tripodi A . Levels of coagulation factors and venous thromboembolism . Haematologica . 2003;88:705–711
  9. Federici AB . The factor VIII/von Willebrand factor complex (Basic and clinical issues) . Haematologica . 2003;88:3–12
  10. Fuster V , Fass DN , Kaye MP , Josa M , Zinsmeister AR , Bowie EJ . Arteriosclerosis in normal and von Willebrand pigs (long-term prospective study and aortic transplantation study) . Circ Res . 1982;51:587–593
  11. Fuster V , Lie JT , Badimon L , Rosemark JA , Badimon JJ , Bowie EJ . Spontaneous and diet-induced coronary atherosclerosis in normal swine and swine with von Willebrand disease . Arteriosclerosis . 1985;5:67–73
  12. Badimon L , Steele P , Badimon JJ , Bowie EJ , Fuster V . Aortic atherosclerosis in pigs with heterozygous von Willebrand disease. Comparison with homozygous von Willebrand and normal pigs . Arteriosclerosis . 1985;5:366–370
  13. Methia N , André P , Denis CV , Economoupolos M , Wagner DD . Localized reduction of atherosclerosis in von Willebrand factor-deficient mice . Blood . 2001;98:1424–1428
  14. Griggs TR , Reddick RL , Sultzer D , Brinkhous KM . Susceptibility to atherosclerosis in aorta and coronary arteries of swine with von Willebrand’s disease . Am J Pathol . 1981;102:137–145
  15. Sultzer DL , Brinkhous KM , Reddick RL , Griggs TR . Effect of carbon monoxide on atherogenesis in normal pigs and pigs with von Willebrand’s disease . Atherosclerosis . 1982;43:303–309
  16. Lamb MA , Manning JE , Reddick RL , Griggs TR . Smooth muscle cell proliferation in response to endothelial injury in coronary arteries of normal and von Willebrand’s disease swine . Arteriosclerosis . 1984;4:84–90
  17. Griggs TR , Bauman RW , Reddick RL , Read MS , Koch GG , Lamb MA . Development of coronary atherosclerosis in swine with severe hypercholesterolemia. Lack of influence of von Willebrand factor or acute intimal injury . Arteriosclerosis . 1986;6:155–165
  18. Nichols TC , Bellinger DA , Johnson TA , Lamb MA , Griggs TR . Von Willebrand’s disease prevents occlusive thrombosis in stenosed and injured porcine coronary arteries . Circ Res . 1986;59:15–26
  19. Nichols TC , Bellinger DA , Tate DA , Reddick RL , Read MS , Koch GG , et al.   Von Willebrand factor an occlusive arterial thrombosis. A study in normal and von Willebrand’s disease pigs with diet-induced hypercholesterolemia and atherosclerosis . Arteriosclerosis . 1990;10:449–461
  20. Nichols TC , Samama C , Bellinger DA , Roussi J , Reddick RL , Bonneau M , et al.   Function of von Willebrand factor after crossed bone marrow transplantation between normal and von willebrand disease pigs (Effect on arterial thrombosis in chimeras) . Proc Natl Acad Sci U S A . 1995;92:2455–2459
  21. Nichols TC , Bellinger DA , Reddick RL , Smith SV , Koch GG , Davis K , et al.   The roles of von Willebrand factor and factor VIII in arterial thrombosis (Studies in canine von Willebrand disease and hemophilia A) . Blood . 1993;81:2644–2651
  22. Kawasaki T , Kaida T , Arnout J , Vermylen J , Hoylaerts MF . A new animal model of thrombophilia confirms that high plasma factor VIII levels are thrombogenic . Thromb Haemost . 1999;81:306–311
  23. Jansson JH , Nilsson TK , Johnson O . von Willebrand factor in plasma (A novel risk factor for recurrent myocardial infarction and death) . Br Heart J . 1991;66:351–355
  24. Meade T , Brozovic M , Chakrabarti R , Haines A , Imeson J , Mellows S , et al.   Haemostatic function and ischaemic heart disease (Principal results of the Northwick Park Heart Study) . Lancet . 1986;2:533–537
  25. Rumley A , Lowe GDO , Sweetnam PM , Yarnell JW , Ford RP . Factor VIII, von Willebrand factor and the risk of major ischaemic heart disease in the Caerphilly Heart Study . Br J Haematol . 1999;105:110–116
  26. Thompson SG , Kienast J , Pyke SD , Haverkate F , van de Loo JC . Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group . N Engl J Med . 1995;332:635–641
  27. Jager A , van Hinsbergh VWM , Kostense PJ , Emeis JJ , Yudkin JS , Nijpels G , et al.   von Willebrand factor, C-reactive protein, and 5-year mortality in diabetic and nondiabetic subjects. The Hoorn Study . Arterioscler Thromb Vasc Biol . 1999;19:3071–3078
  28. Morange PE , Simon C , Alessi MC , Luc G , Arveiler D , Ferrieres J , et al.   Endothelial cell markers and the risk of coronary heart disease . Circulation . 2004;109:1343–1348
  29. Folsom AR , Wu KK , Rosamond WD , Sharret AR , Chambless LE . Prospective study of hemostatic factors and incidence of coronary heart disease. The Atherosclerosis Risk in Communities (ARIC) study . Circulation . 1997;96:1102–1108
  30. Smith FB , Lee AJ , Fowkes FGR , Price JF , Rumley A , Lowe GDO . Hemostatic factors as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study . Arterioscler Thromb Vasc Biol . 1997;17:3321–3325
  31. Catto AJ , Carter AM , Barrett JH , Bamford J , Rice PJ , Grant PJ . von Willebrand factor and factor VIII:C in acute cerebrovascular disease. Relationship to stroke subtype and mortality . Thromb Haemost . 1997;77:1104–1108
  32. Folsom AR , Rosamond WD , Shahar E , Cooper LS , Aleksic N , et al.  The Atherosclerosis Risk in Communities (ARIC) study investigators   Prospective study of markers of hemostatic function with risk of ischemic stroke . Circulation . 1999;100:736–742
  33. S̃rámek A , Bucciarelli P , Federici AB , Mannucci PM , de Rosa V , Castaman G , et al.   Patients with type 3 severe von Willebrand disease are not protected against atherosclerosis. Results from a multicenter study in 47 patients . Circulation . 2004;109:740–744
  34. Rosendaal FR , Varekamp I , Smit C , Bröcker-Vriends AH , van Dijck H , Vandenbroucke JP , et al.   Mortality and causes of death in Dutch haemophiliacs, 1973–86 . Br J Haematol . 1989;71:71–76
  35. Triemstra M , Rosendaal FR , Smit C , Van der Ploeg HM , Briët E . Mortality in patients with hemophilia (Changes in a Dutch population from 1986 to 1992 and 1973 to 1986) . Ann Intern Med . 1995;123:823–827
  36. Allan TM , Dawson AA . ABO blood groups and ischaemic heart disease in men . Br Heart J . 1968;30:377–382
  37. Stormorker H , Erikssen J . Plasma antithrombin III and factor VIII antigen in relation to angiographic findings, aging and blood groups in middle-aged men . Thromb Haemost . 1977;38:874–880
  38. Rice GI , Grant PJ . Factor VIII coagulant activity and antigen in subjects with ischaemic heart disease . Thromb Haemost . 1998;80:757–762
  39. Wilhelmsen L , Svardsudd K , Korsan-Bengtsen K , Larsson B , Welin L , Tibblin G . Fibrinogen as a risk factor for stroke and myocardial infarction . N Engl J Med . 1984;311:501–505
  40. Meade T , Chakrabarti R , Haines A , North W , Stirling Y , Thompson S . Haemostatic function and cardiovascular death (Early results of a prospective study) . Lancet . 1980;1:1050–1054
  41. Tracy RP , Arnold AM , Ettinger W , Fried L , Meilahn E , Savage P . The relationship of fibrinogen and factors VII and VIII to incident cardiovascular disease and death in the elderly. Results from the Cardiovascular Health Study . Arterioscler Thromb Vasc Biol . 1999;19:1776–1783
  42. Karttunen V , Alfthan G , Hiltunen L , Rasi V , Kervinen K , Kesäniemi YA , et al.   Risk factors for cryptogenic ischaemic stroke . Eur J Neurol . 2002;9:625–632
  43. Mannucci PM . Venous thromboembolism in Von Willebrand disease . Thromb Haemost . 2002;88:378–379
  44. Makris M , Colvin B , Gupta V , Shields ML , Smith MP . Venous thrombosis following the use of intermediate purity F VIII concentrate to treat patients with Von Willebrand’s disease . Thromb Haemost . 2002;88:387–388
  45. Stead NW , Bauer KA , Kinney TR , Lewis JG , Campbell EE , Shifman MA , et al.   Venous thrombosis in a family with defective release of vascular plasminogen activator and elevated plasma factor VIII/von Willebrand’s factor . Am J Med . 1983;74:33–39
  46. Nilsson T , Mellbring C , Hedner U . Relationship between factor XII, von Willebrand factor and postoperative deep vein thrombosis . Acta Chir Scand . 1986;152:347–349
  47. Koster T , Blann AD , Briët E , Vandenbroucke JP , Rosendaal FR . Role of clotting factor VIII in effect of von Willebrand factor on occurence of deep-vein thrombosis . Lancet . 1995;345:152–155
  48. Tsai AW , Cushman M , Rosamond WD , Heckbert SR , Tracy RP , Aleksic N , et al.   Coagulation factors, inflammation markers, and venous thromboembolism (The Longitudinal Investigation of Thromboembolism Etiology (LITE)) . Am J Med . 2002;113:636–642
  49. Bucek RA , Reiter M , Quehenberger P , Weltermann A , Kyrle PA , Minar E . Thrombus precursor protein, endogenous thrombin potential, von-Willebrand factor and activated factor VII in suspected deep vein thrombosis (Is there a place for new parameters?) . Br J Haematol . 2003;120:123–128
  50. Kamphuisen PW , Lensen R , Houwing-Duistermaat JJ , Eikenboom JCJ , Harvey M , Bertina RM , et al.   Heritability of elevated factor VIII antigen levels in factor V Leiden families with thrombophilia . Br J Haematol . 2000;109:519–522
  51. Lensen R , Bertina RM , Vandenbroucke JP , Rosendaal FR . High factor VIII levels contribute to the thrombotic risk in families with factor V Leiden . Br J Haematol . 2001;114:380–386
  52. Schambeck CM , Hinney K , Haubitz I , Mansouri Taleghani B , Wahler D . Familial clustering of high factor VIII levels in patients with venous thromboembolism . Arterioscler Thromb Vasc Biol . 2001;21:289–292
  53. Souto JC , Almasy L , Borrel M , Garì M , Martinez E , Mateo J , et al.   Genetic determinants of hemostasis phenotypes in Spanish families . Circulation . 2000;1010:1546–1551
  54. Kamphuisen PW , Eikenboom JCJ , Rosendaal FR , Koster T , Blann AD , Vos HL , et al.   High factor VIII antigen levels increase the risk of venous thrombosis but are not associated with polymorphisms in the von Willebrand factor and factor VIII gene . Br J Haematol . 2001;115:156–158
  55. Mansvelt EP , Laffan M , McVey JH , Tuddenham EG . Analysis of the F8 gene in individuals with high plasma factor VIII:C levels and associated venous thrombosis . Thromb Haemost . 1998;80:561–565
  56. Kamphuisen PW , Eikenboom JCJ , Vos HL , Pablo R , Sturk A , Bertina RM , et al.   Increased levels of factor VIII and fibrinogen in patients with venous thrombosis are not caused by acute phase reactions . Thromb Haemost . 1999;81:680–683
  57. Lowe GDO , Haverkate F , Thompson SG , Turner RM , Bertina RM , Turpie AGG , et al.   Prediction of deep vein thrombosis after elective hip replacement surgery by preoperative clinical and haemostatic variables (The ECAT DVT study) . Thromb Haemost . 1999;81:879–886
  58. Kraaijenhagen RA , in’t Anker PS , Koopman MMW , Reitsma PH , Prins MH , van den Ende A , et al.   High plasma concentration of factor VIIIc is a major risk factor for venous thromboembolism . Thromb Haemost . 2000;83:5–9
  59. O’Donnell J , Tuddenham EGD , Manning R , Kemball-Cook G , Johnson D , Laffan M . High prevalence of elevated factor VIII levels in patients referred for thrombophilia screening (Role of increased synthesis and relationship to the acute phase reaction) . Thromb Haemost . 1997;77:825–828
  60. O’Donnell J , Mumford AD , Manning RA , Laffan M . Elevation of FVIII:C in venous thromboembolism is persistent and independent of the acute phase response . Thromb Haemost . 2000;83:10–13
  61. Kyrle PA , Minar E , Hirschl M , Bialonczyk C , Stain M , Schneider B , et al.   High plasma levels of factor VIII and the risk of recurrent venous thromboembolism . N Engl J Med . 2000;343:457–462
  62. Weiss HJ . von Willebrand factor and platelet function . Ann NY Acad Sci . 1991;614:125–137
  63. Cattaneo M . Role of von Willebrand factor in atherothrombosis . Haematologica . 2001;86:3–5
  64. Galbusera M , Zoja C , Donadelli R , Paris S , Morigi M , Benigni A , et al.   Fluid shear stress modulates von Willebrand factor release from human vascular endothelium . Blood . 1997;90:1558–1564
  65. Ruggeri ZM . Von Willebrand factor . J Clin Invest . 1997;99:559–564
  66. Gill JC , Endres-Brooks J , Bauer PJ , Marks WJ , Montgomery RR . The effect of ABO blood group on the diagnosis of von Willebrand disease . Blood . 1987;69:1691–1695
  67. Jeremic M , Weisert O , Gedde-Dahl TW . Factor VIII (AHG) levels in 1016 regular blood donors (The effects of age, sex, and ABO blood groups) . Scand J Clin Lab Invest . 1976;36:461–466
  68. Ǒrstavik KH , Magnus P , Reisner H , Berg K , Graham JB , Nance W . Factor VIII and factor IX in a twin population (Evidence for a major effect of ABO locus on factor VIII level) . Am J Hum Genet . 1985;37:89–101
  69. Gonzalez-Conejero R , Lozano ML , Rivera J , Corral J , Iniesta JA , Moraleda JM , et al.   Polymorphism of platelet membrane glycoprotein Ibα associated with arterial thrombotic disease . Blood . 1998;92:2771–2776
  70. Dai K , Gao W , Ruan C . The Sma I polymorphism in the von Willebrand factor gene associated with acute ischemic stroke . Thromb Res . 2001;104:389–395
  71. van der Meer IM , Brouwers GJ , Bulk S , Leebeek FWG , van der Kuip DAM , Hofman A , et al.   ; Genetic variability of von Willebrand factor and risk of coronary heart disease (The Rotterdam Study) . Br J Haematol . 2004;124:343–347
  72. O’Donnell J , Mumford AD , Manning RA , Laffan MA . Marked elevation of thrombin generation in patients with elevated FVIII:C and venous thromboembolism . Br J Haematol . 2001;115:678–691
  73. Kamphuisen PW , Eikenboom JCJ , Bertina RM . Elevated factor VIII levels and the risk of thrombosis . Arterioscler Thromb Vasc Biol . 2001;21:731–738
  74. Bombeli T , de Conno E , Jutzi M , Fehr J . In patients symptomatic for deep-vein thrombosis factor VIII elevation is found twice as frequent as in patients symptomatic for pulmonary embolism . Thromb Haemost . 2003;89:198–200
  75. Libourel EJ , Bank I , Meinardi JR , Baljé-Volkers CP , Hamulyak K , Middeldorp S , et al.   Co-segregation of thrombophilic disorders in factor V Leiden carriers; the contributions of factor VIII, factor XI, thrombin activatable fibrinolysis inhibitor and lipoprotein(a) to the absolute risk of venous thromboembolism . Haematologica . 2002;87:1068–1073
  76. Roelse JC , Koopman MM , Buller HR , ten Cate JW , Montaruli B , van Mourik JA , et al.   Absence of mutations at the activated protein C cleavage sites of factor VIII in 125 patients with venous thrombosis . Br J Haematol . 1996;92:740–743
  77. Martinelli I . Pros and cons of thrombophilia testing (Pros) . J Thromb Haemost . 2003;1:410–411
  78. Machin SJ . Pros and cons of thrombophilia testing. Cons . J Thromb Haemost . 2003;1:412–413

PII: S0037-1963(04)00214-8

doi: 10.1053/j.seminhematol.2004.09.009

Seminars in Hematology
Volume 42, Issue 1 , Pages 49-55 , January 2005

Article Tools